InsidersTradesSigma
Follow the 삼진제약 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 삼진제약 has recorded 2 public disclosures. Market capitalisation: €222.9bn. The latest transaction was disclosed on 2 June 2026 (Other). Among the most active insiders: 최승주. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Samjin Pharmaceutical es una empresa farmacéutica surcoreana centrada en la investigación, el desarrollo y la fabricación de medicamentos. Cotiza en el mercado XKRX.